Poliovirus vaccine inactivated - Panacea Biotec

Drug Profile

Poliovirus vaccine inactivated - Panacea Biotec

Alternative Names: Inactivated poliovirus vaccine - Chiron Panacea; Inactivated poliovirus vaccine - Panacea Biotec; Injectable poliovirus vaccine - Panacea Biotec; Polprotec

Latest Information Update: 21 Apr 2016

Price : $50

At a glance

  • Originator Panacea Biotec
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Poliomyelitis

Most Recent Events

  • 20 Apr 2016 No recent reports on development identified - Registered for Poliomyelitis in Bangladesh (IM)
  • 01 Jan 2014 Launched for Poliomyelitis (prevention) in Philippines (IM)
  • 01 Jan 2014 Registered for Poliomyelitis in Bangladesh (prevention) (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top